GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » Debt-to-Revenue

CLS Holdings USA (XCNQ:CLSH) Debt-to-Revenue : 0.46 (As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

CLS Holdings USA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was C$2.72 Mil. CLS Holdings USA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was C$9.60 Mil. CLS Holdings USA's annualized Revenue for the quarter that ended in Feb. 2024 was C$26.60 Mil. CLS Holdings USA's annualized Debt-to-Revenue for the quarter that ended in Feb. 2024 was 0.46.


CLS Holdings USA Debt-to-Revenue Historical Data

The historical data trend for CLS Holdings USA's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Debt-to-Revenue Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.18 1.60 1.16 1.13 0.60

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.62 0.64 0.67 0.46

Competitive Comparison of CLS Holdings USA's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Debt-to-Revenue falls into.



CLS Holdings USA Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

CLS Holdings USA's Debt-to-Revenue for the fiscal year that ended in May. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(8.414 + 10.18) / 31.27
=0.59

CLS Holdings USA's annualized Debt-to-Revenue for the quarter that ended in Feb. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.72 + 9.604) / 26.6
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Feb. 2024) Revenue data.


CLS Holdings USA Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (XCNQ:CLSH) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.